here ya go Pikantari, there are 71 currently in trials of various forms, three that are seeking FDA approval and will go on the market sometime in 2010-2011 (two of them are ORAL!!!!)
mspipeline
these are the phase III trials going on right now. The one in bold below is one of the most promising ones that is due out in 2010 it is a once a day oral treatment. The side effects are mild, and the efficacy is supposed to be in the range of 77% (current treatments are in the 33% range)
BG12 (Biogen)
Campath (aka alemtuzumab) (Genzyme)
Cannabinoids - oral (PPMS) (Clinical Neurology Research Group - Plymouth)
FTY720 (aka fingolimod) (2 trials: RRMS and PPMS) (Novartis)
Interferon beta 1a - PEGylated (bi-weekly or monthly injection) (Biogen Idec)
Laquinimod (aka ABR-215062) (Teva)
MBP8298 (aka Dirucotide) (BioMS) (trial for SPMS)
Minocycline (MS Society of Canada, MS Scientific Research Foundation)
MN-166 (aka ibudilast and Ketas) (Medicinova)
Mycophenolate mofetil (aka Cellcept) (with Avonex)
Mylinax (oral cladribine) (Merck Serono)
Progestin and Estradiol (Hospices Civils de Lyon)
Revimmune (aka high-dose cyclophosphamide or cytoxan) (trial for refractory MS) (Accentia Biopharmaceuticals)
Stem cells - autologous hematopoietic (ASTIMS trial)
T-Cell Vaccination (aka TCV-01-002) (Sheba Medical Center)
Teriflunomide (aka HMR 1726) (Sanofi-Aventis)
Trimesta (oral) (estriol) (with copaxone) (Pipex Pharmaceuticals)